Navigation Links
CuraGen in Medical News

CuraGen Reports First Quarter 2009 Financial Results

...ANFORD, Conn., April 23 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) , today reported its...uring the three month period ended March 31, 2009, curagen utilized $4.1 million of cash and investments for ...n of cash and investments. As of March 31, 2009, curagen had $14 million of outstanding 4% convertible subo...

Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer

...ltant for clients including Genaissance Pharmaceuticals, Amersham Health, G.E. Healthcare and Massachusetts General Hospital. Alsobrook also worked at curagen Corp. as genetics supervisor for drug discovery and as senior research scientist for pharmacogenomics. From 1996-2000, Alsobrook was associate faculty...

CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference

... BRANFORD, Conn., Nov. 5 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...archived for 90 days thereafter. About CuraGen curagen Corporation (Nasdaq: CRGN ) is a dedicated clinic...ng diverse approaches for the treatment of cancer. curagen Corporation is headquartered in Branford, Connecti...

CuraGen to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference

... BRANFORD, Conn., June 6 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today that ...archived for 30 days thereafter. About CuraGen curagen Corporation (Nasdaq: CRGN ) is a clinical-stage b... promising approaches for the treatment of cancer. curagen Corporation is headquartered in Branford, Connecti...

CuraGen Corporation Regains NASDAQ Listing Compliance

... BRANFORD, Conn., May 29 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today announced that ...8, NASDAQ had previously informed the Company that curagen had until July 28, 2008 to regain compliance with ...hank our shareholders who have shown confidence in curagen during this notification period," stated Dr. Timot...

CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million

... BRANFORD, Conn., May 22 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today the c...CuraGen's ownership in belinostat. After expenses, curagen will receive approximately $12 million in cash. ...n April 22, 2008, bring the total cash realized by curagen to approximately $38 million," stated Dr. Timothy ...

Pharsight Strengthens Senior Management Team

...g strategies and implementing solutions to improve R&D productivity. Before this, Dr. Murphy served as Vice President and Chief Information Officer at curagen Corporation, a publicly traded biopharmaceutical company. While at CuraGen, he directed business development and information technology services for t...

CuraGen Reports First Quarter 2008 Financial Results

...RANFORD, Conn., April 22 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today reported its fi...ter of 2008. For the quarter ended March 31, 2008, curagen reported a net loss of $6.8 million, or $0.12 per ...e same period in 2007. During the first quarter, curagen incurred costs totaling $1.5 million for milestone...

CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA

...BRANFORD, Conn., Dec. 10 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...tology (ASH) 49th Annual Meeting in Atlanta, GA. curagen and TopoTarget also reported today that the prelim...tment of PTCL. Based on this meeting with the FDA, curagen plans to submit a clinical trial protocol to the F...

CuraGen Reports Third Quarter 2007 Financial Results

...BRANFORD, Conn., Oct. 25 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...of 2007. For the quarter ended September 30, 2007, curagen reported a net loss of $9.9 million, or $0.18 per ...he same period in 2006. As of September 30, 2007, curagen had cash and investments of $153.6 million. Of the...
CuraGen in Medical Technology

CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer

...RANFORD, Conn., June 17 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today tha...e Professor of Clinical Medicine, /Weill Cornell. curagen anticipates presenting updated results from this s...n antibody-drug conjugate (ADC) being developed by curagen that consists of a fully-human monoclonal antibody...

CuraGen Updates CR011-vcMMAE Data at ASCO

...BRANFORD, Conn., June 2 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) reported three data...n antibody-drug conjugate (ADC) being developed by curagen that consists of a fully-human monoclonal antibody...ancer who have failed other therapies. About curagen CuraGen Corporation (Nasdaq: CRGN ) is a clinica...

CuraGen to Present CR011-vcMMAE Data at ASCO

...BRANFORD, Conn., May 28 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today announced pla...n antibody-drug conjugate (ADC) being developed by curagen that consists of a fully-human monoclonal antibody...n survival is less than nine months. About curagen ...

CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma

... BRANFORD, Conn., Nov. 3 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today preli...g schedules of CR011-vcMMAE," commented Dr. Hwu. curagen is currently enrolling patients into a Phase I por...st cancer who have received previous chemotherapy. curagen anticipates providing updated data from the ongoin...

CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008

...BRANFORD, Conn., Oct. 29 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...ays at http://www.curagen.com . About CuraGen curagen Corporation (Nasdaq: CRGN ) is a dedicated clinic...ng diverse approaches for the treatment of cancer. curagen Corporation is headquartered in Branford, Connecti...

CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma

...RANFORD, Conn., Sept. 11 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...011-vcMMAE for the treatment of advanced melanoma. curagen also announced today that Phase II results from th...rate, time to response and duration of response. curagen is also continuing the Phase I portion of the tria...

CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

...BRANFORD, Conn., July 29 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...011-vcMMAE. For the quarter ended June 30, 2008, curagen reported income from continuing operations of $39....ly negotiated transactions. As of June 30, 2008, curagen had cash, restricted cash and investments of $95.0...

CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer

...BRANFORD, Conn., June 25 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio... Shannon, President and Chief Executive Officer of curagen Corporation. "We are confident in our ability to c...who have failed other therapies. About CuraGen curagen Corporation (Nasdaq: CRGN ) is a dedicated clinic...

CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma

...BRANFORD, Conn., June 11 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio... Shannon, President and Chief Executive Officer of curagen Corporation. "This trial is enrolling well, and we... cancer in the third quarter of 2008. Furthermore, curagen is conducting preclinical research to determine th...

CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma

... BRANFORD, Conn., June 1 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today presented encou... Shannon, President and Chief Executive Officer of curagen Corporation. "Based on these promising results in ...need in this patient population. About CuraGen curagen Corporation (Nasdaq: CRGN ) is a clinical-stage b...
CuraGen in Biological News

Massey researchers induce cell death in leukemia

...of translational research, interactions between bortezomib and romidepsin (Gloucester Pharmaceuticals) and bortezomib with belinostat (aka PXD101 from curagen Corporation and TopoTarget A/S), were examined in human CLL cells isolated from five patients. Bortezomib dramatically potentiated the lethality of bo...
CuraGen in Biological Technology

CuraGen Reports Second Quarter 2009 Financial Results

...RANFORD, Conn., July 31 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today reported its ...are in connection with the proposed merger between curagen Corporation and Celldex Therapeutics, Inc. The se...e three and six month periods ended June 30, 2009, curagen utilized $3.8 million and $7.8 million, respective...

CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009

...BRANFORD, Conn., Jan. 29 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), today reported its f...ng the three month period ended December 31, 2008, curagen utilized $3.8 million of cash and investments and ...on of cash and investments. At December 31, 2008, curagen has outstanding $19 million of 4% convertible subo...

CuraGen Reports Third Quarter 2008 Financial Results

... BRANFORD, Conn., Nov. 3 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), today reported its f...uarter with $91.4 million of cash and investments. curagen expects to utilize an average of $3 to $4 million ...mately $79 to $81 million in cash and investments. curagen is also pursuing partnership opportunities around ...

CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million

... BRANFORD, Conn., May 14 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today the c...discount of approximately 15.1% off of face value. curagen currently has approximately $100 million or $1.72 ...ding. With the completion of these transactions, curagen will eliminate a total of approximately $5.6 milli...

CuraGen Sells Ownership of Belinostat to TopoTarget A/S

... - curagen to receive approximately $45 million in cash, stoc...RANFORD, Conn., April 22 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...to future net sales and sublicenses of belinostat. curagen will no longer have any funding requirements for b...

TopoTarget Successfully Buys Back Full Control of Belinostat

...duct TopoTarget Acquires US & RoW Rights From curagen Corporation COPENHAGEN, April 22 /PRNewswire/ --...tiple cancer indications jointly by TopoTarget and curagen Corporation since 2004. TopoTarget, which has alre... its flexible dosing, and its lack of toxicity." curagen has accepted to sell their rights back to TopoTarg...

CuraGen to Present at the BIO CEO & Investor Conference

...BRANFORD, Conn., Feb. 12 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today that ...'s website until March 13, 2008. About CuraGen curagen Corporation (Nasdaq: CRGN ) is a dedicated clinic...g development strengths cultivated over the years, curagen expects to make a difference by advancing its prom...

CuraGen Reports Fourth Quarter and Year End 2007 Financial Results

...BRANFORD, Conn., Jan. 31 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today reported its co...quarter and fiscal year ended December 31, 2007. curagen reported a loss from operations for the fourth qua...r of 2006. For the year ended December 31, 2007, curagen reported a loss from operations of $59.6 million, ...

CuraGen Corporation Receives Notification from NASDAQ

...BRANFORD, Conn., Jan. 29 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio... 28, 2008, from The NASDAQ Stock Market, notifying curagen that during the preceding 30 consecutive trading d...e effect on the listing of CuraGen's common stock. curagen is considering alternatives to regain compliance w...

CuraGen Corporation Announces Appointment of Sean Cassidy as CFO

...BRANFORD, Conn., Dec. 20 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio... Company. "We are pleased to welcome Sean to the curagen team," commented Timothy Shannon, President and Ch...ve Wurzer for his more than 10 years of service to curagen during which he made substantial contributions acr...
Other Tags
(Date:1/22/2015)... 22, 2015 Woodloch Pines, an all-inclusive ... selected by TripAdvisor as the number one best large hotel ... in the world for their annual Travelers’ Choice Awards. ... . The website is home to millions of unbiased and ...
(Date:1/22/2015)... 22, 2015 The Incredible Bulk is a ... to increase lean muscle by up to 30lbs in less ... attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , ... a step-by-step, scientific diet formula that allows the body to ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
(Date:1/22/2015)... has released a new blog post explaining the main features ... , Auto insurance quotes help many drivers find the best ... call an agent or visit an agency for price information. ... http://autocarinsurancebest.com/ . , Every business who relies heavily on ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... addition of the "Global Wearable Technologies Market ... Share, Overview, Trends and Forecast 2014-2020" report ... Technologies are smart devices that can be worn ...
(Date:1/22/2015)... CHARLOTTE, N.C. , Jan. 22, 2015 Infinisource has ... introduction of the G2 model. The G2 sets a higher ... company,s iSolved human capital management solution. With plug-and-play installation, touch ... G2 time clock provides a robust time collection solution for ...
(Date:12/22/2014)... , Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces it ... Robbins for the 2015 International CES debut of the ... will be at the NXT-ID booth January 6th and ...
Breaking Biology News(10 mins):Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2Infinisource's NXG series sets new time clock standard 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4
Other Contents